Inaugural Bile-Incretin-Microbiome meeting on Friday October 31, 2014
Invitation: Center for Diabetes Research at Gentofte Hospital will host the inaugural Bile-Incretin-Microbiome (BIMG) meeting on Friday October 31, 2014. The meeting will focus on bile acids, incretins and gut microbiota and feature lectures by Danish and international top scientists. The meeting is financed by Danish Diabetes Academy.
Call for Post Doc Fellowship applications
Danish Diabetes Academy hereby call for Post Doc fellowship applications. Online submission of applications is now open. All interested candidates with a Master’s Degree and PhD Degree in health science or basic science and technology can apply for a maximum of one Post Doc position each.
Working with diabetes?
Join our website - share knowledge and communicate with researchers globallyJoin now
The Juvenile Diabetes Research Foundation (JDRF) and the Danish Diabetes Academy (the Academy) are pleased to announce that they are partnering on all JDRF Requests for Applications (RFAs) in the fiscal year of 2015 (July 1, 2014 – June 30, 2015)Read more
IDEA Summit 2014
An invitation to attend the IDEA Summit in France in early December 2014, an event dedicated to collaboration, translational research and technology transfer in diabetes. Danish Diabetes Academy members benefit from a 25% discount on the registration fees.Read more
Browse our event calendar and get informed about dates of upcoming Danish Diabetes Academy related events and funding callsRead more
Browse our website to get the latest news regarding Danish Diabetes Academy related events and diabetes researchRead more
Symposium on Fetal Programming
Sign up before 1 November 2014More...
Annual Day 2014
On November 12, 2014, Danish Diabetes Academy celebrates its second year in existence and you are invited.More...
Mark your calenders on 5th of February 2015 for the endo-cardiology symposium.More...
Call for Post Doc applications
Danish Diabetes Academy advertises six Post doc fellowships.More...
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
Degradation-resistant glucagon-like peptide-1 (GLP-1), mimetics and GLP-1 enhancers have been used for treatment of type 2 diabetes mellitus since 200...Written by: Nicolai J. W. Albrechtsen Read full review